Lindbrook Capital’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $917 | Sell |
34
-153
| -82% | -$4.13K | ﹤0.01% | 2487 |
|
|
2024
Q4 | $6.71K | Buy |
187
+100
| +115% | +$3.59K | ﹤0.01% | 1847 |
|
|
2024
Q3 | $3.3K | Sell |
87
-104
| -54% | -$3.94K | ﹤0.01% | 2177 |
|
|
2024
Q2 | $8.64K | Sell |
191
-57
| -23% | -$2.58K | ﹤0.01% | 1708 |
|
|
2024
Q1 | $12K | Sell |
248
-74
| -23% | -$3.59K | ﹤0.01% | 1467 |
|
|
2023
Q4 | $17.3K | Buy |
322
+185
| +135% | +$9.92K | ﹤0.01% | 1259 |
|
|
2023
Q3 | $8.03K | Sell |
137
-8
| -6% | -$469 | ﹤0.01% | 1524 |
|
|
2023
Q2 | $9.14K | Sell |
145
-21
| -13% | -$1.32K | ﹤0.01% | 1516 |
|
|
2023
Q1 | $10.4K | Buy |
166
+9
| +6% | +$566 | ﹤0.01% | 1430 |
|
|
2022
Q4 | $8.35K | Buy |
157
+35
| +29% | +$1.86K | ﹤0.01% | 1524 |
|
|
2022
Q3 | $7K | Buy |
122
+14
| +13% | +$803 | ﹤0.01% | 1519 |
|
|
2022
Q2 | $8K | Sell |
108
-3
| -3% | -$222 | ﹤0.01% | 1369 |
|
|
2022
Q1 | $9K | Buy |
111
+8
| +8% | +$649 | ﹤0.01% | 1350 |
|
|
2021
Q4 | $10K | Hold |
103
| – | – | ﹤0.01% | 1285 |
|
|
2021
Q3 | $9K | Hold |
103
| – | – | ﹤0.01% | 1056 |
|
|
2021
Q2 | $11K | Hold |
103
| – | – | ﹤0.01% | 1031 |
|
|
2021
Q1 | $10K | Hold |
103
| – | – | ﹤0.01% | 1032 |
|
|
2020
Q4 | $8K | Hold |
103
| – | – | ﹤0.01% | 1014 |
|
|
2020
Q3 | $8K | Hold |
103
| – | – | ﹤0.01% | 931 |
|
|
2020
Q2 | $8K | Hold |
103
| – | – | ﹤0.01% | 926 |
|
|
2020
Q1 | $6K | Buy |
+103
| New | +$6K | ﹤0.01% | 948 |
|